# Prospect Capital Corp: financial statements, quarterly

PSEC · Nasdaq · CIK 1287032 · [Other](/sectors/other.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/psec.md) · [Financials](/companies/psec/financials.md) · [Filings](/companies/psec/filings.md) · [Insiders](/companies/psec/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/psec/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | not reported | [40.0](/filings/0001287032-24-000043.md) | [39.8](/filings/0001287032-24-000152.md) | [39.8 d](/filings/0001287032-24-000280.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [117](/filings/0001287032-24-000408.md) | [(27.7)](/filings/0001287032-25-000012.md) | [144](/filings/0001287032-25-000115.md) | [29.6 d](/filings/0001287032-26-000269.md) | [(134)](/filings/0001287032-25-000339.md) | [(0.1)](/filings/0001287032-26-000045.md) | [(140)](/filings/0001287032-26-000164.md) | [(196) d](/filings/0001287032-26-000269.md) | [78.0](/filings/0001287032-25-000339.md) | [23.7](/filings/0001287032-26-000045.md) | [56.5](/filings/0001287032-26-000164.md) | [(4.5) d](/filings/0001287032-26-000269.md) |
| Diluted EPS | $ per share | [0.18](/filings/0001287032-24-000408.md) | [(0.13)](/filings/0001287032-25-000012.md) | [0.20](/filings/0001287032-25-000115.md) | not reported | [(0.38)](/filings/0001287032-25-000339.md) | [(0.07)](/filings/0001287032-26-000045.md) | [(0.39)](/filings/0001287032-26-000164.md) | not reported | [0.08](/filings/0001287032-25-000339.md) | [(0.01)](/filings/0001287032-26-000045.md) | [0.05](/filings/0001287032-26-000164.md) | not reported |
| Basic EPS | $ per share | [0.23](/filings/0001287032-24-000408.md) | [(0.13)](/filings/0001287032-25-000012.md) | [0.27](/filings/0001287032-25-000115.md) | not reported | [(0.38)](/filings/0001287032-25-000339.md) | [(0.07)](/filings/0001287032-26-000045.md) | [(0.39)](/filings/0001287032-26-000164.md) | not reported | [0.10](/filings/0001287032-25-000339.md) | [(0.01)](/filings/0001287032-26-000045.md) | [0.05](/filings/0001287032-26-000164.md) | not reported |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [97.3](/filings/0001287032-24-000043.md) | [53.5](/filings/0001287032-24-000152.md) | [85.9](/filings/0001287032-25-000232.md) | [57.0](/filings/0001287032-24-000408.md) | [59.8](/filings/0001287032-25-000012.md) | [54.5](/filings/0001287032-25-000115.md) | [50.8](/filings/0001287032-26-000269.md) | [86.5](/filings/0001287032-25-000339.md) | [38.1](/filings/0001287032-26-000045.md) | [34.6](/filings/0001287032-26-000164.md) | [43.6](/filings/0001287032-26-000269.md) |
| Total assets | $m | not reported | [7,781](/filings/0001287032-24-000043.md) | [7,906](/filings/0001287032-24-000152.md) | [7,857](/filings/0001287032-25-000232.md) | [7,593](/filings/0001287032-24-000408.md) | [7,235](/filings/0001287032-25-000012.md) | [6,996](/filings/0001287032-25-000115.md) | [6,805](/filings/0001287032-26-000269.md) | [6,642](/filings/0001287032-25-000339.md) | [6,535](/filings/0001287032-26-000045.md) | [6,384](/filings/0001287032-26-000164.md) | [6,449](/filings/0001287032-26-000269.md) |
| Total liabilities | $m | not reported | [2,597](/filings/0001287032-24-000043.md) | [2,604](/filings/0001287032-24-000152.md) | [2,559](/filings/0001287032-25-000232.md) | [2,470](/filings/0001287032-24-000408.md) | [2,164](/filings/0001287032-25-000012.md) | [2,119](/filings/0001287032-25-000115.md) | [2,186](/filings/0001287032-26-000269.md) | [2,013](/filings/0001287032-25-000339.md) | [1,952](/filings/0001287032-26-000045.md) | [1,817](/filings/0001287032-26-000164.md) | [1,945](/filings/0001287032-26-000269.md) |
| Long-term debt | $m | not reported | [2,470](/filings/0001287032-24-000043.md) | [2,484](/filings/0001287032-24-000152.md) | [2,434](/filings/0001287032-25-000232.md) | [2,274](/filings/0001287032-24-000408.md) | [2,058](/filings/0001287032-25-000012.md) | [2,028](/filings/0001287032-25-000115.md) | [2,088](/filings/0001287032-26-000269.md) | [1,921](/filings/0001287032-25-000339.md) | [1,848](/filings/0001287032-26-000045.md) | [1,732](/filings/0001287032-26-000164.md) | [1,861](/filings/0001287032-26-000269.md) |
| Shareholders' equity | $m | [3,781](/filings/0001287032-25-000012.md) | [3,684](/filings/0001287032-25-000115.md) | [3,742](/filings/0001287032-25-000115.md) | [3,712](/filings/0001287032-26-000269.md) | [3,511](/filings/0001287032-26-000045.md) | [3,440](/filings/0001287032-26-000164.md) | [3,245](/filings/0001287032-26-000164.md) | [2,989](/filings/0001287032-26-000269.md) | [3,005](/filings/0001287032-26-000045.md) | [2,959](/filings/0001287032-26-000164.md) | [2,954](/filings/0001287032-26-000164.md) | [2,929](/filings/0001287032-26-000269.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [95.1](/filings/0001287032-24-000408.md) | [79.4 d](/filings/0001287032-25-000012.md) | [(22.3) d](/filings/0001287032-25-000115.md) | [128 d](/filings/0001287032-26-000269.md) | [174](/filings/0001287032-25-000339.md) | [279 d](/filings/0001287032-26-000045.md) | [78.6 d](/filings/0001287032-26-000164.md) | [(7.6) d](/filings/0001287032-26-000269.md) | [279](/filings/0001287032-25-000339.md) | [85.6 d](/filings/0001287032-26-000045.md) | [196 d](/filings/0001287032-26-000164.md) | [(43.9) d](/filings/0001287032-26-000269.md) |
| Dividends paid | $m | [73.3](/filings/0001287032-24-000408.md) | [74.1 d](/filings/0001287032-25-000012.md) | [74.7 d](/filings/0001287032-25-000115.md) | [75.6 d](/filings/0001287032-25-000232.md) | [77.4](/filings/0001287032-25-000339.md) | [65.6 d](/filings/0001287032-26-000045.md) | [60.0 d](/filings/0001287032-26-000164.md) | [61.2 d](/filings/0001287032-26-000269.md) | [62.4](/filings/0001287032-25-000339.md) | [63.9 d](/filings/0001287032-26-000045.md) | [65.4 d](/filings/0001287032-26-000164.md) | [58.0 d](/filings/0001287032-26-000269.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | period not labelled (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [394](/filings/0001287032-22-000375.md) | [547](/filings/0001287032-24-000043.md) | [400](/filings/0001287032-24-000152.md) | [636](/filings/0001287032-24-000408.md) | [411](/filings/0001287032-25-000012.md) | [678](/filings/0001287032-25-000115.md) | [429](/filings/0001287032-25-000339.md) | [437](/filings/0001287032-26-000045.md) | [443](/filings/0001287032-26-000164.md) | [877](/filings/0001287032-25-000339.md) | [472](/filings/0001287032-26-000045.md) | [930](/filings/0001287032-26-000164.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 524,832,496 at 2026-08-19, from the cover of the [10-K filed 2026-08-20](/filings/0001287032-26-000269.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.